United States Healthcare Equipment & Supplies

Procept Biorobotics Corp (PRCT)

Track

Procept Biorobotics Corp executives recently engaged in multiple planned divestments. These transactions occurred amid a 22.8% decline in share value over ninety days. Following the latest results financiers, leadership activity remains exclusively focused on selling equity, reflecting a net negative position for corporate insiders during this period of significant market volatility.
Ticker: PRCT Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Procept Biorobotics Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 7 Aug 2026
Value US$802,518.69 | Price 142.39 | Shares 32,797 (+27.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-10 2026-08-07 B Purchase
2.2
Wood Larry L

President, CEO

Executive Director
32,797 +27.6%
142.39
US$802,519 		32,797 +27.6% 142.39 US$802,519
2026-06-10 2026-06-08 S Sale
2.6
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
34,257 -41.3%
431.54
US$624,997 		34,257 -41.3% 431.54 US$624,997
2026-06-10 2026-06-08 S Sale
3.2
Waters Kevin

EVP, CFO

Officer
67,503 +15.2%
301.13
US$3,307,677 		67,503 +15.2% 301.13 US$3,307,677
2026-06-10 2026-06-08 PlS Planned sale
Templin Barry L

EVP, Chief Technology Officer

Officer
358 -0.5%
28.48
US$10,195 		358 -0.5% 28.48 US$10,195
2026-06-08 2026-06-08 PrS Proposed sale
2.6
Nouri Alaleh

Officer

Officer
285
28.48
US$8,117 		285 28.48 US$8,117
2026-06-08 2026-06-08 PrS Proposed sale
Templin Barry L

Officer

Officer
358
28.48
US$10,195 		358 28.48 US$10,195
2026-06-08 2026-06-08 PrS Proposed sale
3.2
Waters Kevin

Officer

Officer
357
28.48
US$10,167 		357 28.48 US$10,167
2026-03-19 2026-03-19 PlS Planned sale
2.6
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
2,332 -2.2%
26.15
US$60,972 		2,332 -2.2% 26.15 US$60,972
2026-03-19 2026-03-19 PlS Planned sale
2.6
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
3,031 -2.7%
25.82
US$78,258 		3,031 -2.7% 25.82 US$78,258
2026-03-19 2026-03-19 PrS Proposed sale
2.6
Alalah Nouri

Officer

Officer
5,363
26.17
US$140,349 		5,363 26.17 US$140,349
2026-03-19 2026-03-17 S Sale
2.6
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
304 -0.3%
28.15
US$8,559 		304 -0.3% 28.15 US$8,559
2026-03-19 2026-03-17 S Sale
3.2
Waters Kevin

EVP, CFO

Officer
706 -0.5%
28.15
US$19,876 		706 -0.5% 28.15 US$19,876
2026-03-17 2026-03-17 PrS Proposed sale
2.6
Nouri Alaleh

Officer

Officer
304
28.15
US$8,559 		304 28.15 US$8,559
2026-03-17 2026-03-17 PrS Proposed sale
3.2
Waters Kevin

Officer

Officer
706
28.15
US$19,876 		706 28.15 US$19,876
2026-03-12 2026-03-10 PlS Planned sale
2.6
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
145 -0.1%
26.74
US$3,877 		145 -0.1% 26.74 US$3,877
2026-03-12 2026-03-10 PlS Planned sale
2.6
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
145 -0.1%
26.74
US$3,877 		145 -0.1% 26.74 US$3,877
2026-03-12 2026-03-10 PlS Planned sale
2.6
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
3,098 -2.7%
25.60
US$79,320 		3,098 -2.7% 25.60 US$79,320
2026-03-12 2026-03-10 PlS Planned sale
2.6
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
3,098 -2.7%
25.60
US$79,320 		3,098 -2.7% 25.60 US$79,320
2026-03-10 2026-03-10 PrS Proposed sale
2.6
Alalah Nouri

Officer

Officer
3,243
25.26
US$81,918 		3,243 25.26 US$81,918
2026-03-09 2026-03-09 B Purchase
1.9
Desai Antal Rohit
Non-Executive Director
1,300 +0.3%
25.42
US$33,042 		1,300 +0.3% 25.42 US$33,042
2026-03-09 2026-03-09 B Purchase
1.9
Desai Antal Rohit
Non-Executive Director
53,818 +14.5%
24.91
US$1,340,348 		53,818 +14.5% 24.91 US$1,340,348
2026-03-09 2026-03-09 B Purchase
1.9
Desai Antal Rohit
Non-Executive Director
43,581 +13.3%
24.08
US$1,049,500 		43,581 +13.3% 24.08 US$1,049,500
2026-03-09 2026-03-06 B Purchase
1.9
Desai Antal Rohit
Non-Executive Director
53,763 +19.6%
24.10
US$1,295,790 		53,763 +19.6% 24.10 US$1,295,790
2026-03-09 2026-03-06 B Purchase
1.9
Desai Antal Rohit
Non-Executive Director
106,554 +63.7%
23.33
US$2,485,713 		106,554 +63.7% 23.33 US$2,485,713
2026-03-09 2026-03-06 S Sale
2.6
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
6,892 -5.7%
23.70
US$163,353 		6,892 -5.7% 23.70 US$163,353
2026-03-09 2026-03-06 S Sale
3.2
Waters Kevin

EVP, CFO

Officer
6,721 -4.2%
23.70
US$159,300 		6,721 -4.2% 23.70 US$159,300
2026-03-06 2026-03-06 PrS Proposed sale
2.6
Nouri Alaleh

Officer

Officer
6,892
23.70
US$163,353 		6,892 23.70 US$163,353
2026-03-06 2026-03-06 PrS Proposed sale
3.2
Waters Kevin

Officer

Officer
6,721
23.70
US$159,300 		6,721 23.70 US$159,300
2026-03-09 2026-03-05 B Purchase
1.9
Desai Antal Rohit
Non-Executive Director
24,748 +17.4%
26.41
US$653,528 		24,748 +17.4% 26.41 US$653,528
2026-03-09 2026-03-05 B Purchase
1.9
Desai Antal Rohit
Non-Executive Director
142,498 +inf%
25.44
US$3,625,021 		142,498 +inf% 25.44 US$3,625,021
2025-08-14 2025-08-13 B Purchase
1.6
MOLL FREDERIC H
Non-Executive Director
20,000 +2.4%
39.26
US$785,138 		20,000 +2.4% 39.26 US$785,138
2025-06-12 2025-06-12 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
5,049 -26.0%
62.33
US$314,693 		5,049 -26.0% 62.33 US$314,693
2025-06-12 2025-06-12 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
19,951 -50.7%
61.28
US$1,222,563 		19,951 -50.7% 61.28 US$1,222,563
2025-06-12 2025-06-11 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
5,717 -12.7%
64.27
US$367,447 		5,717 -12.7% 64.27 US$367,447
2025-06-12 2025-06-11 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
11,495 -20.3%
63.47
US$729,603 		11,495 -20.3% 63.47 US$729,603
2025-06-12 2025-06-11 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
7,788 -12.1%
62.59
US$487,476 		7,788 -12.1% 62.59 US$487,476
2025-06-12 2025-06-10 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
1,726 -2.6%
64.67
US$111,625 		1,726 -2.6% 64.67 US$111,625
2025-06-12 2025-06-10 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
18,412 -21.8%
64.02
US$1,178,683 		18,412 -21.8% 64.02 US$1,178,683
2025-06-12 2025-06-10 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
4,862 -5.4%
63.23
US$307,403 		4,862 -5.4% 63.23 US$307,403
2025-06-06 2025-06-06 PrS Proposed sale
3.9
SHAM SHIBLAQ

Officer; Director

Executive Director
20,000
64.13
US$1,282,638 		20,000 64.13 US$1,282,638
2025-06-06 2025-06-06 S Sale
3.9
Shiblaq Hisham

EVP, Chief Comm. Officer

Officer
1,800 -2.8%
65.35
US$117,631 		1,800 -2.8% 65.35 US$117,631
2025-06-06 2025-06-06 S Sale
3.9
Shiblaq Hisham

EVP, Chief Comm. Officer

Officer
5,904 -8.3%
64.64
US$381,610 		5,904 -8.3% 64.64 US$381,610
2025-06-06 2025-06-06 S Sale
3.9
Shiblaq Hisham

EVP, Chief Comm. Officer

Officer
12,296 -14.8%
63.71
US$783,397 		12,296 -14.8% 63.71 US$783,397
2025-06-05 2025-06-05 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
100 -0.1%
66.73
US$6,673 		100 -0.1% 66.73 US$6,673
2025-06-05 2025-06-05 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
4,000 -4.3%
65.94
US$263,762 		4,000 -4.3% 65.94 US$263,762
2025-06-05 2025-06-05 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
12,548 -11.8%
65.09
US$816,802 		12,548 -11.8% 65.09 US$816,802
2025-06-05 2025-06-05 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
5,946 -5.3%
64.19
US$381,690 		5,946 -5.3% 64.19 US$381,690
2025-06-05 2025-06-05 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
1,706 -1.5%
63.07
US$107,606 		1,706 -1.5% 63.07 US$107,606
2025-06-05 2025-06-05 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
700 -0.6%
61.85
US$43,297 		700 -0.6% 61.85 US$43,297
2025-06-05 2025-06-04 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
8,600 -7.0%
61.40
US$528,052 		8,600 -7.0% 61.40 US$528,052
2025-06-05 2025-06-04 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
16,400 -11.8%
60.82
US$997,504 		16,400 -11.8% 60.82 US$997,504
2025-06-05 2025-06-03 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
1,518 -1.1%
61.83
US$93,856 		1,518 -1.1% 61.83 US$93,856
2025-06-05 2025-06-03 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
11,602 -7.6%
61.22
US$710,228 		11,602 -7.6% 61.22 US$710,228
2025-06-05 2025-06-03 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
9,880 -6.1%
60.23
US$595,094 		9,880 -6.1% 60.23 US$595,094
2025-06-05 2025-06-03 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
1,100 -0.7%
59.14
US$65,059 		1,100 -0.7% 59.14 US$65,059
2025-06-05 2025-06-03 PlS Planned sale
1.9
Desai Antal Rohit
Non-Executive Director
900 -0.5%
58.04
US$52,238 		900 -0.5% 58.04 US$52,238
2025-06-03 2025-06-03 PrS Proposed sale
1.9
222 DNA TRUST

Director

Non-Executive Director
150,000
57.94
US$8,691,000 		150,000 57.94 US$8,691,000
2025-03-19 2025-03-18 S Sale
3.3
Zadno Reza

President, CEO

Executive Director
5,475 -3.1%
57.06
US$312,404 		5,475 -3.1% 57.06 US$312,404
2025-03-19 2025-03-18 S Sale
3.2
Waters Kevin

EVP, CFO

Officer
733 -0.7%
57.06
US$41,825 		733 -0.7% 57.06 US$41,825
2025-03-19 2025-03-18 S Sale
3.9
Shiblaq Hisham

EVP, Chief Comm. Officer

Officer
247 -0.4%
57.06
US$14,094 		247 -0.4% 57.06 US$14,094
2025-03-19 2025-03-18 S Sale
2.6
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
316 -0.5%
57.06
US$18,031 		316 -0.5% 57.06 US$18,031
2025-03-18 2025-03-18 PrS Proposed sale
3.3
Zadno Reza

Officer; Director

Executive Director
5,475
57.06
US$312,404 		5,475 57.06 US$312,404
2025-03-18 2025-03-18 PrS Proposed sale
3.2
Waters Kevin

Officer

Officer
733
57.06
US$41,825 		733 57.06 US$41,825
2025-03-18 2025-03-18 PrS Proposed sale
3.9
Shiblaq Hisham

Officer

Officer
247
57.06
US$14,094 		247 57.06 US$14,094
2025-03-18 2025-03-18 PrS Proposed sale
2.6
Nouri Alaleh

Officer

Officer
316
57.06
US$18,031 		316 57.06 US$18,031
2025-03-10 2025-03-06 S Sale
2.6
Nouri Alaleh

EVP, CLO, CORP. SEC.

Officer
3,641 -5.6%
61.31
US$223,230 		3,641 -5.6% 61.31 US$223,230
2025-03-10 2025-03-06 S Sale
3.9
Shiblaq Hisham

EVP, Chief Comm. Officer

Officer
3,588 -5.4%
61.31
US$219,980 		3,588 -5.4% 61.31 US$219,980
2025-03-10 2025-03-06 S Sale
3.2
Waters Kevin

EVP, CFO

Officer
3,662 -3.3%
61.31
US$224,517 		3,662 -3.3% 61.31 US$224,517
2025-03-10 2025-03-06 S Sale
3.3
Zadno Reza

President, CEO

Executive Director
15,916 -8.2%
61.31
US$975,810 		15,916 -8.2% 61.31 US$975,810
2025-03-06 2025-03-06 PrS Proposed sale
3.3
Zadno Reza

Officer

Officer
15,916
61.31
US$975,735 		15,916 61.31 US$975,735
2025-03-06 2025-03-06 PrS Proposed sale
3.2
Waters Kevin

Officer

Officer
3,662
61.31
US$224,500 		3,662 61.31 US$224,500
2025-03-06 2025-03-06 PrS Proposed sale
3.9
Shiblaq Hisham

Officer

Officer
3,588
61.31
US$219,963 		3,588 61.31 US$219,963
2025-03-06 2025-03-06 PrS Proposed sale
2.6
Nouri Alaleh

Officer

Officer
3,641
61.31
US$223,212 		3,641 61.31 US$223,212
2024-12-06 2024-12-04 PlS Planned sale
3.3
Zadno Reza

President, CEO

Executive Director
2,235 -1.4%
99.04
US$221,359 		2,235 -1.4% 99.04 US$221,359
2024-12-06 2024-12-04 PlS Planned sale
3.3
Zadno Reza

President, CEO

Executive Director
5,126 -3.2%
98.09
US$502,808 		5,126 -3.2% 98.09 US$502,808
Explore more

More insider trading research around Procept Biorobotics Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America